[1]
Bukhari, N. and Winquist, E. 2017. Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. Canadian Urological Association Journal. 11, 11 (Nov. 2017), E449–50. DOI:https://doi.org/10.5489/cuaj.4519.